

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 6.75934665 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.50715743 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.18120970 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.80348337 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49137262 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.28891703 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.28891703 |
| 8 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.17588621 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.03868856 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.03213899 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.03213899 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.03213899 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 5.03213899 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 5.03213899 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.03213899 |
| 16 | regulation of activation of Janus kinase activity (GO:0010533) | 4.94993533 |
| 17 | T-helper 1 type immune response (GO:0042088) | 4.93879977 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.77363248 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.74586695 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.74302437 |
| 21 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.68786362 |
| 22 | cellular response to zinc ion (GO:0071294) | 4.65610630 |
| 23 | B cell proliferation (GO:0042100) | 4.64341732 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.60975920 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.58937662 |
| 26 | negative thymic T cell selection (GO:0045060) | 4.58538244 |
| 27 | regulation of sequestering of triglyceride (GO:0010889) | 4.56750255 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.53746643 |
| 29 | detection of bacterium (GO:0016045) | 4.50088229 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 4.44663046 |
| 31 | negative T cell selection (GO:0043383) | 4.37591082 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.34663994 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.31643168 |
| 34 | striated muscle atrophy (GO:0014891) | 4.28947454 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.27306784 |
| 36 | detection of other organism (GO:0098543) | 4.25095491 |
| 37 | skeletal muscle adaptation (GO:0043501) | 4.23472171 |
| 38 | thymic T cell selection (GO:0045061) | 4.19147001 |
| 39 | positive T cell selection (GO:0043368) | 4.10976898 |
| 40 | tricarboxylic acid cycle (GO:0006099) | 4.09288064 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.09133615 |
| 42 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.07058732 |
| 43 | B cell homeostasis (GO:0001782) | 4.05683975 |
| 44 | carnitine shuttle (GO:0006853) | 4.02975146 |
| 45 | plasma membrane repair (GO:0001778) | 3.97635597 |
| 46 | muscle filament sliding (GO:0030049) | 3.96482349 |
| 47 | actin-myosin filament sliding (GO:0033275) | 3.96482349 |
| 48 | T cell selection (GO:0045058) | 3.96040337 |
| 49 | positive regulation of interleukin-12 production (GO:0032735) | 3.95095312 |
| 50 | germinal center formation (GO:0002467) | 3.90676856 |
| 51 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.89181357 |
| 52 | sarcomere organization (GO:0045214) | 3.88345060 |
| 53 | T cell migration (GO:0072678) | 3.82872676 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.80243382 |
| 55 | fatty acid transmembrane transport (GO:1902001) | 3.80142986 |
| 56 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.80130982 |
| 57 | B cell mediated immunity (GO:0019724) | 3.78365985 |
| 58 | defense response to protozoan (GO:0042832) | 3.78290467 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.75522947 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.73979621 |
| 61 | leukocyte aggregation (GO:0070486) | 3.72574303 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.70512313 |
| 63 | response to interleukin-15 (GO:0070672) | 3.69496401 |
| 64 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.69435039 |
| 65 | muscle atrophy (GO:0014889) | 3.67349617 |
| 66 | myofibril assembly (GO:0030239) | 3.65168116 |
| 67 | regulation of antigen processing and presentation (GO:0002577) | 3.62623677 |
| 68 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.62380249 |
| 69 | regulation of skeletal muscle contraction (GO:0014819) | 3.60908881 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58542383 |
| 71 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.54084363 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 3.50359639 |
| 73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47387374 |
| 74 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.47325062 |
| 75 | intracellular lipid transport (GO:0032365) | 3.46953959 |
| 76 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.43020766 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.42490031 |
| 78 | response to protozoan (GO:0001562) | 3.41892449 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.41866921 |
| 80 | negative regulation of phagocytosis (GO:0050765) | 3.39716184 |
| 81 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.38787562 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 3.37685959 |
| 83 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.37245398 |
| 84 | cardiac myofibril assembly (GO:0055003) | 3.36304543 |
| 85 | regulation of cholesterol storage (GO:0010885) | 3.36149394 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34883062 |
| 87 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34402815 |
| 88 | response to host immune response (GO:0052572) | 3.34337930 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34337930 |
| 90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33407271 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33195363 |
| 92 | positive regulation of type 2 immune response (GO:0002830) | 3.32526806 |
| 93 | lymphocyte homeostasis (GO:0002260) | 3.30015824 |
| 94 | regulation of B cell proliferation (GO:0030888) | 3.27849064 |
| 95 | growth hormone receptor signaling pathway (GO:0060396) | 3.26872201 |
| 96 | positive regulation of B cell activation (GO:0050871) | 3.26780813 |
| 97 | positive regulation of lipid storage (GO:0010884) | 3.25590141 |
| 98 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.25316888 |
| 99 | positive regulation of B cell proliferation (GO:0030890) | 3.25258133 |
| 100 | neutrophil activation involved in immune response (GO:0002283) | 3.24496061 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24038845 |
| 102 | positive regulation of Rap GTPase activity (GO:0032854) | 3.23612363 |
| 103 | regulation of memory T cell differentiation (GO:0043380) | 3.22890827 |
| 104 | T cell costimulation (GO:0031295) | 3.21657855 |
| 105 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21657434 |
| 106 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.21091984 |
| 107 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.20498922 |
| 108 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.19461183 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17561990 |
| 110 | respiratory burst (GO:0045730) | 3.17185507 |
| 111 | lymphocyte costimulation (GO:0031294) | 3.16876644 |
| 112 | response to host (GO:0075136) | 3.16199137 |
| 113 | response to host defenses (GO:0052200) | 3.16199137 |
| 114 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16199137 |
| 115 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.15458793 |
| 116 | actin-mediated cell contraction (GO:0070252) | 3.14727163 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 3.14427582 |
| 118 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.12203547 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.11572383 |
| 120 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.11154450 |
| 121 | Peyers patch development (GO:0048541) | 3.11154450 |
| 122 | carnitine transmembrane transport (GO:1902603) | 3.09984709 |
| 123 | detection of external biotic stimulus (GO:0098581) | 3.09017220 |
| 124 | regulation of T-helper cell differentiation (GO:0045622) | 3.08413798 |
| 125 | cellular response to virus (GO:0098586) | 3.07744402 |
| 126 | negative regulation of lipid storage (GO:0010888) | 3.07460868 |
| 127 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.07195333 |
| 128 | T cell homeostasis (GO:0043029) | 3.06009946 |
| 129 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.05492535 |
| 130 | regulation of interleukin-12 production (GO:0032655) | 3.03629354 |
| 131 | regulation of relaxation of muscle (GO:1901077) | 3.02930216 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 3.02380090 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 3.01892491 |
| 134 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.01328520 |
| 135 | regulation of coenzyme metabolic process (GO:0051196) | 2.99738915 |
| 136 | regulation of cofactor metabolic process (GO:0051193) | 2.99738915 |
| 137 | negative regulation of interleukin-17 production (GO:0032700) | 2.98840380 |
| 138 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98202793 |
| 139 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.97929172 |
| 140 | response to muramyl dipeptide (GO:0032495) | 2.96882535 |
| 141 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.96126420 |
| 142 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94039691 |
| 143 | mononuclear cell proliferation (GO:0032943) | 2.91349071 |
| 144 | negative regulation of B cell proliferation (GO:0030889) | 2.91232050 |
| 145 | carnitine transport (GO:0015879) | 2.90833349 |
| 146 | amino-acid betaine transport (GO:0015838) | 2.90833349 |
| 147 | lymphocyte proliferation (GO:0046651) | 2.89806841 |
| 148 | regulation of T-helper 1 type immune response (GO:0002825) | 2.89767347 |
| 149 | regulation of fatty acid oxidation (GO:0046320) | 2.89740698 |
| 150 | regulation of B cell activation (GO:0050864) | 2.89689817 |
| 151 | regulation of natural killer cell differentiation (GO:0032823) | 2.89590712 |
| 152 | type I interferon signaling pathway (GO:0060337) | 2.89434168 |
| 153 | cellular response to type I interferon (GO:0071357) | 2.89434168 |
| 154 | leukocyte homeostasis (GO:0001776) | 2.88374173 |
| 155 | creatine metabolic process (GO:0006600) | 2.87639666 |
| 156 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87353334 |
| 157 | cellular response to interferon-alpha (GO:0035457) | 2.86963779 |
| 158 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86938077 |
| 159 | NADH metabolic process (GO:0006734) | 2.86849109 |
| 160 | tricarboxylic acid metabolic process (GO:0072350) | 2.86151849 |
| 161 | response to type I interferon (GO:0034340) | 2.85839375 |
| 162 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.85792085 |
| 163 | positive regulation of interleukin-2 production (GO:0032743) | 2.85763400 |
| 164 | regulation of immunoglobulin secretion (GO:0051023) | 2.84834803 |
| 165 | valine metabolic process (GO:0006573) | 2.82688964 |
| 166 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.81864169 |
| 167 | cellular response to growth hormone stimulus (GO:0071378) | 2.81202797 |
| 168 | positive regulation of natural killer cell activation (GO:0032816) | 2.80319608 |
| 169 | fatty acid beta-oxidation (GO:0006635) | 2.78296817 |
| 170 | negative regulation of viral genome replication (GO:0045071) | 2.77769812 |
| 171 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.77731058 |
| 172 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77640994 |
| 173 | neutrophil activation (GO:0042119) | 2.76832984 |
| 174 | 2-oxoglutarate metabolic process (GO:0006103) | 2.76752646 |
| 175 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.76602234 |
| 176 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74522438 |
| 177 | granulocyte activation (GO:0036230) | 2.71184293 |
| 178 | regulation of lipid storage (GO:0010883) | 2.68151672 |
| 179 | monocyte chemotaxis (GO:0002548) | 2.67941559 |
| 180 | muscle adaptation (GO:0043500) | 2.67448737 |
| 181 | positive regulation of interleukin-17 production (GO:0032740) | 2.66488278 |
| 182 | cellular response to interferon-beta (GO:0035458) | 2.65677650 |
| 183 | response to peptidoglycan (GO:0032494) | 2.61964146 |
| 184 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.60672226 |
| 185 | skeletal muscle contraction (GO:0003009) | 2.59151566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.59874294 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.58129332 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.54702267 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.82848117 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.25351144 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.60263899 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.34681644 |
| 8 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.07787316 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.86424070 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.72781028 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.67569528 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.64530296 |
| 13 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.62796822 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54468328 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51725094 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.43904404 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.43573260 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.43547901 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43114688 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.35260428 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28561616 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.23629391 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.23424359 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.17547380 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16989482 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11420197 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08180410 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03267394 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.00926705 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.99637349 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98908068 |
| 32 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.96221272 |
| 33 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.96221272 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95504679 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94807465 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.94437738 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93827261 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92127878 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91860577 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80110493 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79697188 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77981957 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.76274153 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72636155 |
| 45 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70798554 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67976024 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66461203 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61534940 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60808725 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60310068 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57175246 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.55993841 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55447117 |
| 54 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54314280 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53075477 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52054396 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.49137385 |
| 58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.46580957 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44525392 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41360911 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39281306 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37904145 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36533500 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36413394 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35505009 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34034924 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.32346134 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31664724 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29902484 |
| 70 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.27785240 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27563996 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24996423 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24047952 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23981996 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23608927 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22795899 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.21946847 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21530863 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21525992 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21500457 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21440298 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21191065 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19529407 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18819811 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17900945 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16104353 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15952454 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14726010 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13644859 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13158464 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12208419 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11919817 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11589403 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10854731 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10854731 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.07261917 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07136424 |
| 98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07039237 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06644953 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02233484 |
| 101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02098723 |
| 102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01519456 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00991592 |
| 104 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99800466 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99709537 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 0.99673439 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99088591 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97696640 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97437992 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96967574 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96489080 |
| 112 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96369210 |
| 113 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96302439 |
| 114 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95201150 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94564110 |
| 116 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93424602 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93064549 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93018629 |
| 119 | P300_27268052_Chip-Seq_Bcells_Human | 0.92594041 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92392717 |
| 121 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91920069 |
| 122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91920069 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90918818 |
| 124 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90076752 |
| 125 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89338925 |
| 126 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88277919 |
| 127 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.88247716 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87864938 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87862032 |
| 130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86918400 |
| 131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85343520 |
| 132 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85134143 |
| 133 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.83538590 |
| 134 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83527080 |
| 135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83443915 |
| 136 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.83367476 |
| 137 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83169376 |
| 138 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82957344 |
| 139 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82875688 |
| 140 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.82848348 |
| 141 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82787632 |
| 142 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82634344 |
| 143 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82517055 |
| 144 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81942552 |
| 145 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81400062 |
| 146 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80298688 |
| 147 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.78193463 |
| 148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77948086 |
| 149 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76978425 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74795142 |
| 151 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74709231 |
| 152 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.74691098 |
| 153 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.74648154 |
| 154 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.73257085 |
| 155 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73096126 |
| 156 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.72391012 |
| 157 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72284759 |
| 158 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71494920 |
| 159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71258399 |
| 160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70299379 |
| 161 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69993851 |
| 162 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69549701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.27205958 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.79835348 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.79419647 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.23525153 |
| 5 | MP0004510_myositis | 3.11277971 |
| 6 | MP0000751_myopathy | 3.06489278 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.87110534 |
| 8 | MP0000749_muscle_degeneration | 2.78868639 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.78224754 |
| 10 | MP0002398_abnormal_bone_marrow | 2.72702728 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.72560116 |
| 12 | MP0004130_abnormal_muscle_cell | 2.63728881 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.49322451 |
| 14 | MP0000716_abnormal_immune_system | 2.41629541 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.40608348 |
| 16 | MP0005330_cardiomyopathy | 2.38615405 |
| 17 | MP0009785_altered_susceptibility_to | 2.35916823 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.32985049 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.32953045 |
| 20 | MP0000685_abnormal_immune_system | 2.32340668 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.31066091 |
| 22 | MP0005670_abnormal_white_adipose | 2.16802085 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.13844066 |
| 24 | MP0001873_stomach_inflammation | 2.06428506 |
| 25 | MP0002722_abnormal_immune_system | 2.06417764 |
| 26 | MP0003436_decreased_susceptibility_to | 2.01553074 |
| 27 | MP0002429_abnormal_blood_cell | 1.99436381 |
| 28 | MP0004782_abnormal_surfactant_physiolog | 1.99401807 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.98185798 |
| 30 | MP0001348_abnormal_lacrimal_gland | 1.96173102 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.95968631 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.92713515 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.91643796 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.89288043 |
| 35 | MP0001346_abnormal_lacrimal_gland | 1.88796538 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.86310914 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.85730423 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.85560063 |
| 39 | MP0005451_abnormal_body_composition | 1.85519311 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.81808986 |
| 41 | MP0001544_abnormal_cardiovascular_syste | 1.81808986 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.76311484 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.73494308 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.71369971 |
| 45 | MP0001853_heart_inflammation | 1.69704448 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.67507481 |
| 47 | MP0003828_pulmonary_edema | 1.66231456 |
| 48 | MP0005387_immune_system_phenotype | 1.65766077 |
| 49 | MP0001790_abnormal_immune_system | 1.65766077 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.57610418 |
| 51 | MP0002971_abnormal_brown_adipose | 1.57029003 |
| 52 | MP0000759_abnormal_skeletal_muscle | 1.56939969 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.56758751 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.56234755 |
| 55 | MP0002269_muscular_atrophy | 1.54978374 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.53015046 |
| 57 | MP0000343_altered_response_to | 1.52811606 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.50096030 |
| 59 | MP0006138_congestive_heart_failure | 1.49772990 |
| 60 | MP0004233_abnormal_muscle_weight | 1.49371436 |
| 61 | MP0002006_tumorigenesis | 1.47727105 |
| 62 | MP0004947_skin_inflammation | 1.47307889 |
| 63 | MP0005025_abnormal_response_to | 1.45437482 |
| 64 | MP0005369_muscle_phenotype | 1.42343108 |
| 65 | MP0002419_abnormal_innate_immunity | 1.38471513 |
| 66 | MP0008260_abnormal_autophagy | 1.36818537 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.34907935 |
| 68 | MP0003724_increased_susceptibility_to | 1.33319242 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.32298651 |
| 70 | MP0002090_abnormal_vision | 1.31258117 |
| 71 | MP0003866_abnormal_defecation | 1.31008552 |
| 72 | MP0004381_abnormal_hair_follicle | 1.30736326 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.29943662 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 1.29713442 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.29610707 |
| 76 | MP0002009_preneoplasia | 1.28611993 |
| 77 | MP0008057_abnormal_DNA_replication | 1.26383621 |
| 78 | MP0005671_abnormal_response_to | 1.26261029 |
| 79 | MP0005535_abnormal_body_temperature | 1.26251180 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.25274951 |
| 81 | MP0003303_peritoneal_inflammation | 1.23704610 |
| 82 | MP0000747_muscle_weakness | 1.22674249 |
| 83 | MP0003448_altered_tumor_morphology | 1.22541468 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20919715 |
| 85 | MP0006082_CNS_inflammation | 1.20312647 |
| 86 | MP0004484_altered_response_of | 1.20041366 |
| 87 | MP0000490_abnormal_crypts_of | 1.18549762 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.18120819 |
| 89 | MP0000733_abnormal_muscle_development | 1.17808476 |
| 90 | MP0005375_adipose_tissue_phenotype | 1.16849602 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 1.14442879 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.13664422 |
| 93 | MP0009840_abnormal_foam_cell | 1.13541264 |
| 94 | MP0009764_decreased_sensitivity_to | 1.10274808 |
| 95 | MP0002723_abnormal_immune_serum | 1.08800186 |
| 96 | MP0002019_abnormal_tumor_incidence | 1.05911168 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 1.05149706 |
| 98 | MP0003172_abnormal_lysosome_physiology | 1.04884492 |
| 99 | MP0005310_abnormal_salivary_gland | 1.03886974 |
| 100 | MP0002132_abnormal_respiratory_system | 1.03625361 |
| 101 | MP0003091_abnormal_cell_migration | 1.01123916 |
| 102 | MP0001800_abnormal_humoral_immune | 0.95887616 |
| 103 | MP0009115_abnormal_fat_cell | 0.95409816 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.95331471 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.92502994 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.91689267 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.91507711 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.91494181 |
| 109 | MP0001819_abnormal_immune_cell | 0.87374116 |
| 110 | MP0002933_joint_inflammation | 0.86638976 |
| 111 | MP0009278_abnormal_bone_marrow | 0.85516103 |
| 112 | MP0003077_abnormal_cell_cycle | 0.84966882 |
| 113 | MP0002166_altered_tumor_susceptibility | 0.84084440 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.82338606 |
| 115 | MP0008469_abnormal_protein_level | 0.82293486 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.80024604 |
| 117 | MP0002254_reproductive_system_inflammat | 0.79980846 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.79872425 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.79872425 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.79365937 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.79360261 |
| 122 | MP0010094_abnormal_chromosome_stability | 0.78016571 |
| 123 | MP0001663_abnormal_digestive_system | 0.77819544 |
| 124 | MP0005166_decreased_susceptibility_to | 0.77499999 |
| 125 | MP0003186_abnormal_redox_activity | 0.75930111 |
| 126 | MP0002163_abnormal_gland_morphology | 0.74300291 |
| 127 | MP0002405_respiratory_system_inflammati | 0.73472441 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.73151185 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.72751279 |
| 130 | MP0005334_abnormal_fat_pad | 0.72374698 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.71365684 |
| 132 | MP0002928_abnormal_bile_duct | 0.71250008 |
| 133 | MP0000313_abnormal_cell_death | 0.70404153 |
| 134 | MP0001851_eye_inflammation | 0.69050803 |
| 135 | MP0003045_fibrosis | 0.67986867 |
| 136 | MP0009763_increased_sensitivity_to | 0.67339401 |
| 137 | MP0002877_abnormal_melanocyte_morpholog | 0.66060072 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.63507232 |
| 139 | MP0003111_abnormal_nucleus_morphology | 0.63063578 |
| 140 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62784999 |
| 141 | MP0008874_decreased_physiological_sensi | 0.62020176 |
| 142 | MP0002295_abnormal_pulmonary_circulatio | 0.61533970 |
| 143 | MP0000858_altered_metastatic_potential | 0.61397339 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.61231032 |
| 145 | MP0005645_abnormal_hypothalamus_physiol | 0.59387380 |
| 146 | MP0000249_abnormal_blood_vessel | 0.58139658 |
| 147 | MP0000350_abnormal_cell_proliferation | 0.56357029 |
| 148 | MP0005621_abnormal_cell_physiology | 0.54375342 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.51828434 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.51406511 |
| 151 | MP0000609_abnormal_liver_physiology | 0.46564874 |
| 152 | MP0003656_abnormal_erythrocyte_physiolo | 0.46387999 |
| 153 | MP0003693_abnormal_embryo_hatching | 0.45061136 |
| 154 | MP0002083_premature_death | 0.44519961 |
| 155 | MP0005076_abnormal_cell_differentiation | 0.41522599 |
| 156 | MP0004883_abnormal_blood_vessel | 0.40625164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.46959205 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 6.67435369 |
| 3 | Meningitis (HP:0001287) | 5.39551146 |
| 4 | Cellulitis (HP:0100658) | 5.30085254 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.23691397 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.97667475 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.97314046 |
| 8 | Muscle fiber splitting (HP:0003555) | 4.87549032 |
| 9 | Sudden death (HP:0001699) | 4.73615538 |
| 10 | Lymphopenia (HP:0001888) | 4.69151579 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.61418644 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 4.61310029 |
| 13 | Myoglobinuria (HP:0002913) | 4.60087916 |
| 14 | Recurrent viral infections (HP:0004429) | 4.58488289 |
| 15 | Recurrent sinusitis (HP:0011108) | 4.48905329 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 4.44250702 |
| 17 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.35317810 |
| 18 | Colitis (HP:0002583) | 4.30625105 |
| 19 | Recurrent fungal infections (HP:0002841) | 4.29103913 |
| 20 | Calf muscle hypertrophy (HP:0008981) | 4.22900521 |
| 21 | Verrucae (HP:0200043) | 4.15874394 |
| 22 | Papilloma (HP:0012740) | 4.15874394 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 4.05027607 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.05027607 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.96414747 |
| 26 | Difficulty running (HP:0009046) | 3.94408452 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.94050869 |
| 28 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.93396649 |
| 29 | Increased connective tissue (HP:0009025) | 3.88854700 |
| 30 | Osteomyelitis (HP:0002754) | 3.84612763 |
| 31 | Muscle fiber inclusion bodies (HP:0100299) | 3.79307297 |
| 32 | Emphysema (HP:0002097) | 3.76519846 |
| 33 | IgM deficiency (HP:0002850) | 3.75871722 |
| 34 | Abnormality of the calf musculature (HP:0001430) | 3.72857669 |
| 35 | Ventricular tachycardia (HP:0004756) | 3.68894358 |
| 36 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.65164197 |
| 37 | Rhabdomyolysis (HP:0003201) | 3.60482268 |
| 38 | Encephalitis (HP:0002383) | 3.55056961 |
| 39 | IgA deficiency (HP:0002720) | 3.52502466 |
| 40 | Atrial fibrillation (HP:0005110) | 3.50406344 |
| 41 | Increased IgM level (HP:0003496) | 3.47286005 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 3.46285637 |
| 43 | Lipoatrophy (HP:0100578) | 3.40649489 |
| 44 | Recurrent pneumonia (HP:0006532) | 3.39867601 |
| 45 | EMG: myopathic abnormalities (HP:0003458) | 3.38558452 |
| 46 | Recurrent skin infections (HP:0001581) | 3.35356613 |
| 47 | Obstructive lung disease (HP:0006536) | 3.34612698 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 3.34612698 |
| 49 | Restrictive lung disease (HP:0002091) | 3.29683381 |
| 50 | Primary atrial arrhythmia (HP:0001692) | 3.21883389 |
| 51 | Subaortic stenosis (HP:0001682) | 3.21629538 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.21629538 |
| 53 | Recurrent lower respiratory tract infections (HP:0002783) | 3.21498304 |
| 54 | Increased IgE level (HP:0003212) | 3.21019125 |
| 55 | IgG deficiency (HP:0004315) | 3.20965743 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 3.20074355 |
| 57 | Abnormality of T cells (HP:0002843) | 3.16017993 |
| 58 | Nemaline bodies (HP:0003798) | 3.09994948 |
| 59 | Sepsis (HP:0100806) | 3.09347668 |
| 60 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.03086634 |
| 61 | Supraventricular tachycardia (HP:0004755) | 3.00816131 |
| 62 | Supraventricular arrhythmia (HP:0005115) | 2.97461634 |
| 63 | Viral hepatitis (HP:0006562) | 2.95638719 |
| 64 | Lymphoma (HP:0002665) | 2.95240799 |
| 65 | Eczematoid dermatitis (HP:0000976) | 2.92351688 |
| 66 | Abnormality of B cell number (HP:0010975) | 2.90408783 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.90118060 |
| 68 | B lymphocytopenia (HP:0010976) | 2.86543438 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.83557608 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.80874001 |
| 71 | Muscle stiffness (HP:0003552) | 2.79895831 |
| 72 | Urticaria (HP:0001025) | 2.79865581 |
| 73 | T lymphocytopenia (HP:0005403) | 2.79404950 |
| 74 | Palpitations (HP:0001962) | 2.78011707 |
| 75 | Chronic diarrhea (HP:0002028) | 2.76038620 |
| 76 | Facial diplegia (HP:0001349) | 2.75551508 |
| 77 | Dilated cardiomyopathy (HP:0001644) | 2.71506268 |
| 78 | Bronchitis (HP:0012387) | 2.71251384 |
| 79 | Recurrent otitis media (HP:0000403) | 2.66399044 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.66236381 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 2.65410546 |
| 82 | Skin rash (HP:0000988) | 2.63361606 |
| 83 | Chest pain (HP:0100749) | 2.62718190 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.61884321 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.61884321 |
| 86 | Prolonged QT interval (HP:0001657) | 2.61209768 |
| 87 | Increased muscle lipid content (HP:0009058) | 2.59479991 |
| 88 | Frequent falls (HP:0002359) | 2.58244596 |
| 89 | Recurrent abscess formation (HP:0002722) | 2.54779748 |
| 90 | Hypoplasia of the thymus (HP:0000778) | 2.54584701 |
| 91 | Tetraparesis (HP:0002273) | 2.54519885 |
| 92 | Granulocytopenia (HP:0001913) | 2.54031698 |
| 93 | Spontaneous hematomas (HP:0007420) | 2.53573022 |
| 94 | Bundle branch block (HP:0011710) | 2.53450539 |
| 95 | Stomatitis (HP:0010280) | 2.53135886 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.52577097 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.52393878 |
| 98 | Congenital stationary night blindness (HP:0007642) | 2.52145141 |
| 99 | Pustule (HP:0200039) | 2.51916558 |
| 100 | Chronic otitis media (HP:0000389) | 2.49282388 |
| 101 | Hypoglycemic coma (HP:0001325) | 2.43518714 |
| 102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40934992 |
| 103 | Basal ganglia calcification (HP:0002135) | 2.40476201 |
| 104 | Axonal loss (HP:0003447) | 2.37586880 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.34850859 |
| 106 | Central scotoma (HP:0000603) | 2.34702901 |
| 107 | Increased variability in muscle fiber diameter (HP:0003557) | 2.34222834 |
| 108 | Skin ulcer (HP:0200042) | 2.34017695 |
| 109 | Distal lower limb muscle weakness (HP:0009053) | 2.33634684 |
| 110 | Syncope (HP:0001279) | 2.33553164 |
| 111 | Retrobulbar optic neuritis (HP:0100654) | 2.33202913 |
| 112 | Optic neuritis (HP:0100653) | 2.33202913 |
| 113 | Leukopenia (HP:0001882) | 2.32853769 |
| 114 | Chronic sinusitis (HP:0011109) | 2.31624698 |
| 115 | Orchitis (HP:0100796) | 2.31621698 |
| 116 | Generalized aminoaciduria (HP:0002909) | 2.31433162 |
| 117 | Malignant hyperthermia (HP:0002047) | 2.29810787 |
| 118 | Myotonia (HP:0002486) | 2.29798391 |
| 119 | Gastrointestinal infarctions (HP:0005244) | 2.29344706 |
| 120 | Ventricular arrhythmia (HP:0004308) | 2.28696036 |
| 121 | Generalized muscle weakness (HP:0003324) | 2.28620704 |
| 122 | Basal cell carcinoma (HP:0002671) | 2.27969683 |
| 123 | Recurrent bacterial skin infections (HP:0005406) | 2.27901653 |
| 124 | Distal arthrogryposis (HP:0005684) | 2.25571337 |
| 125 | Neck muscle weakness (HP:0000467) | 2.25484387 |
| 126 | Cerebral hemorrhage (HP:0001342) | 2.24009659 |
| 127 | Dicarboxylic aciduria (HP:0003215) | 2.23889756 |
| 128 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23889756 |
| 129 | Vasculitis (HP:0002633) | 2.22647265 |
| 130 | Abnormality of the prostate (HP:0008775) | 2.22248965 |
| 131 | Distal lower limb amyotrophy (HP:0008944) | 2.21660387 |
| 132 | Neoplasm of head and neck (HP:0012288) | 2.20469259 |
| 133 | Esophageal neoplasm (HP:0100751) | 2.20469259 |
| 134 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14519010 |
| 135 | Ketoacidosis (HP:0001993) | 2.13980021 |
| 136 | Heart block (HP:0012722) | 2.13969227 |
| 137 | Tinnitus (HP:0000360) | 2.13809228 |
| 138 | Autoimmune hemolytic anemia (HP:0001890) | 2.13049065 |
| 139 | Abnormality of macrophages (HP:0004311) | 2.12738869 |
| 140 | Hyperglycinuria (HP:0003108) | 2.09954079 |
| 141 | Hepatic necrosis (HP:0002605) | 2.09913068 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 2.09611393 |
| 143 | Gowers sign (HP:0003391) | 2.09412395 |
| 144 | Abnormal atrioventricular conduction (HP:0005150) | 2.08152550 |
| 145 | Severe combined immunodeficiency (HP:0004430) | 2.08047912 |
| 146 | Keratoconjunctivitis sicca (HP:0001097) | 2.07854165 |
| 147 | Hypochromic anemia (HP:0001931) | 2.05867600 |
| 148 | Hypergammaglobulinemia (HP:0010702) | 2.05689191 |
| 149 | Porencephaly (HP:0002132) | 2.05233273 |
| 150 | Atrioventricular block (HP:0001678) | 2.04601848 |
| 151 | Epistaxis (HP:0000421) | 2.02815095 |
| 152 | Hemoptysis (HP:0002105) | 2.01923507 |
| 153 | Hepatitis (HP:0012115) | 1.97672374 |
| 154 | Areflexia of lower limbs (HP:0002522) | 1.97154113 |
| 155 | Keratoconjunctivitis (HP:0001096) | 1.96490414 |
| 156 | Abnormality of the pleura (HP:0002103) | 1.95508442 |
| 157 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.95327198 |
| 158 | Abnormality of the fingertips (HP:0001211) | 1.94642085 |
| 159 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94293378 |
| 160 | Eosinophilia (HP:0001880) | 1.94171424 |
| 161 | Arthralgia (HP:0002829) | 1.92855373 |
| 162 | Fatigue (HP:0012378) | 1.91998357 |
| 163 | Neutropenia (HP:0001875) | 1.91187758 |
| 164 | Hypertensive crisis (HP:0100735) | 1.90790289 |
| 165 | Gingivitis (HP:0000230) | 1.90055038 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.89462220 |
| 167 | Leukocytosis (HP:0001974) | 1.88868563 |
| 168 | Myopathic facies (HP:0002058) | 1.88678869 |
| 169 | Papilledema (HP:0001085) | 1.87607746 |
| 170 | Pheochromocytoma (HP:0002666) | 1.86986380 |
| 171 | Abnormality of the peritoneum (HP:0002585) | 1.84916372 |
| 172 | Albinism (HP:0001022) | 1.83764850 |
| 173 | Scapular winging (HP:0003691) | 1.83635969 |
| 174 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82214650 |
| 175 | Arterial thrombosis (HP:0004420) | 1.81966355 |
| 176 | Proximal tubulopathy (HP:0000114) | 1.80904964 |
| 177 | Myositis (HP:0100614) | 1.79241743 |
| 178 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.79144799 |
| 179 | Villous atrophy (HP:0011473) | 1.79144799 |
| 180 | Ventricular fibrillation (HP:0001663) | 1.79069826 |
| 181 | Muscular dystrophy (HP:0003560) | 1.78417030 |
| 182 | Hyperalaninemia (HP:0003348) | 1.76379352 |
| 183 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.76379352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.51014339 |
| 2 | TTN | 4.00296481 |
| 3 | PRPF4B | 3.65235407 |
| 4 | OBSCN | 3.12335248 |
| 5 | MAP3K10 | 2.75645298 |
| 6 | TBK1 | 2.68404510 |
| 7 | TRIB3 | 2.50122087 |
| 8 | PIM2 | 2.38170393 |
| 9 | TYK2 | 2.37042572 |
| 10 | JAK3 | 2.36600753 |
| 11 | BCKDK | 2.36085146 |
| 12 | BTK | 2.27900579 |
| 13 | PHKG1 | 2.25016614 |
| 14 | PHKG2 | 2.25016614 |
| 15 | MAP3K13 | 2.13239809 |
| 16 | SMG1 | 2.10049274 |
| 17 | IKBKB | 2.09428273 |
| 18 | PDK3 | 2.04723152 |
| 19 | PDK4 | 2.04723152 |
| 20 | SIK2 | 1.84656099 |
| 21 | RIPK4 | 1.82702008 |
| 22 | JAK1 | 1.79215108 |
| 23 | TNK2 | 1.77648136 |
| 24 | EPHB1 | 1.77403382 |
| 25 | SIK3 | 1.68344399 |
| 26 | FES | 1.65738580 |
| 27 | DMPK | 1.63388571 |
| 28 | EPHA3 | 1.62949472 |
| 29 | ARAF | 1.60708599 |
| 30 | BMX | 1.58901074 |
| 31 | LMTK2 | 1.55726562 |
| 32 | LYN | 1.54113014 |
| 33 | GRK6 | 1.48855689 |
| 34 | CSF1R | 1.48847330 |
| 35 | PDK2 | 1.46335108 |
| 36 | CHUK | 1.42751918 |
| 37 | NEK9 | 1.37224615 |
| 38 | PKN2 | 1.34311420 |
| 39 | IKBKE | 1.33848849 |
| 40 | RIPK1 | 1.31736583 |
| 41 | ITK | 1.23909815 |
| 42 | MAP3K5 | 1.21022522 |
| 43 | MAP3K7 | 1.13886251 |
| 44 | CDK4 | 1.13730915 |
| 45 | BMPR2 | 1.09705238 |
| 46 | STK10 | 1.08539711 |
| 47 | TEC | 1.08363329 |
| 48 | IRAK4 | 1.08362527 |
| 49 | LCK | 1.07908983 |
| 50 | IRAK3 | 1.07619389 |
| 51 | STK24 | 1.05392570 |
| 52 | SIK1 | 1.04332116 |
| 53 | TXK | 1.04141235 |
| 54 | TAOK1 | 1.03656133 |
| 55 | PINK1 | 1.02235039 |
| 56 | MYLK | 0.98170647 |
| 57 | MAP3K11 | 0.95189686 |
| 58 | CDC42BPA | 0.93309892 |
| 59 | BLK | 0.92790250 |
| 60 | PIK3CA | 0.92479412 |
| 61 | PBK | 0.91106323 |
| 62 | CAMK1D | 0.88733856 |
| 63 | ABL2 | 0.85778486 |
| 64 | MARK2 | 0.85582264 |
| 65 | KIT | 0.85560398 |
| 66 | JAK2 | 0.85391413 |
| 67 | FGFR4 | 0.84142314 |
| 68 | EEF2K | 0.83772100 |
| 69 | NEK1 | 0.83003649 |
| 70 | TRPM7 | 0.82067322 |
| 71 | PDK1 | 0.80069739 |
| 72 | PKN1 | 0.77840286 |
| 73 | MAP3K8 | 0.77659203 |
| 74 | MARK3 | 0.76859345 |
| 75 | MAP2K3 | 0.76728349 |
| 76 | RAF1 | 0.74335216 |
| 77 | PRKAA2 | 0.73517987 |
| 78 | TAOK2 | 0.73213674 |
| 79 | TESK2 | 0.71641994 |
| 80 | PRKAA1 | 0.70380223 |
| 81 | PTK2B | 0.69646231 |
| 82 | MOS | 0.69414568 |
| 83 | DAPK3 | 0.68419001 |
| 84 | STK4 | 0.67691186 |
| 85 | MAPK12 | 0.66039945 |
| 86 | PIM1 | 0.65582219 |
| 87 | EIF2AK2 | 0.64725984 |
| 88 | PASK | 0.64570432 |
| 89 | NME2 | 0.64149712 |
| 90 | ZAK | 0.63212390 |
| 91 | FGR | 0.63120569 |
| 92 | PIK3CG | 0.62793963 |
| 93 | LRRK2 | 0.62497109 |
| 94 | PAK3 | 0.62234450 |
| 95 | SYK | 0.61495832 |
| 96 | PRKD2 | 0.60415509 |
| 97 | MUSK | 0.60164047 |
| 98 | FGFR3 | 0.59982807 |
| 99 | WNK1 | 0.58553124 |
| 100 | CSK | 0.57505591 |
| 101 | PRKD1 | 0.57268893 |
| 102 | KSR2 | 0.56727829 |
| 103 | STK38L | 0.56315270 |
| 104 | MAP4K1 | 0.55996741 |
| 105 | ICK | 0.55889000 |
| 106 | TIE1 | 0.54808158 |
| 107 | HIPK2 | 0.54286855 |
| 108 | ROCK1 | 0.53889508 |
| 109 | MAPK7 | 0.53659935 |
| 110 | FLT3 | 0.53518162 |
| 111 | HCK | 0.52387065 |
| 112 | MAP3K9 | 0.52358029 |
| 113 | RPS6KA1 | 0.51163085 |
| 114 | FYN | 0.50892306 |
| 115 | IRAK2 | 0.50546770 |
| 116 | PTK6 | 0.50527583 |
| 117 | PDPK1 | 0.50354227 |
| 118 | CDK19 | 0.48456724 |
| 119 | GRK7 | 0.48276233 |
| 120 | TGFBR2 | 0.47482278 |
| 121 | IRAK1 | 0.47192192 |
| 122 | ILK | 0.46036682 |
| 123 | ERBB3 | 0.45951281 |
| 124 | PDGFRA | 0.44089127 |
| 125 | INSRR | 0.43728451 |
| 126 | WNK4 | 0.43551728 |
| 127 | ERN1 | 0.42882153 |
| 128 | TESK1 | 0.42783382 |
| 129 | ZAP70 | 0.42479203 |
| 130 | PRKACG | 0.41177932 |
| 131 | MAPK4 | 0.39499643 |
| 132 | MAP3K3 | 0.39389566 |
| 133 | BRD4 | 0.39047112 |
| 134 | MELK | 0.38457037 |
| 135 | MAPK11 | 0.37532099 |
| 136 | BCR | 0.37443442 |
| 137 | MAP3K1 | 0.37216051 |
| 138 | TAOK3 | 0.37170427 |
| 139 | PRKCD | 0.37026315 |
| 140 | PRKCH | 0.36302872 |
| 141 | CAMKK1 | 0.35931537 |
| 142 | PRKCE | 0.35663795 |
| 143 | PRKCQ | 0.35517174 |
| 144 | TLK1 | 0.33861717 |
| 145 | RET | 0.33824082 |
| 146 | ALK | 0.33239805 |
| 147 | MAPKAPK2 | 0.33123984 |
| 148 | CDK12 | 0.32525311 |
| 149 | MAP2K2 | 0.32220653 |
| 150 | KDR | 0.32007446 |
| 151 | YES1 | 0.29267325 |
| 152 | STK11 | 0.28543376 |
| 153 | MATK | 0.27827305 |
| 154 | NLK | 0.26838831 |
| 155 | CDK9 | 0.25484662 |
| 156 | MAPK3 | 0.23492415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.41982802 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.82034173 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.35593897 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.19035086 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98697006 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.56733584 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.41594786 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37041203 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.29037680 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17929397 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12287859 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06067906 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.04986719 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02467407 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97715363 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.94243596 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.94241958 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81250046 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76082622 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75834558 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72207510 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69523236 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59050721 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.57267309 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.56423313 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54931622 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52230384 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50724012 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49478979 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.48974564 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48831078 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46269870 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45203701 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.42524858 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.36996870 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35450255 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32316165 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29753407 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29385380 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29302867 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.28107379 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.28008283 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.25689094 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.22350050 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17762957 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16992648 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11200542 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10678158 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07123810 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02370711 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 1.01194654 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.00745695 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99308163 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96664845 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91272577 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91020545 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90213399 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90069699 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.88673721 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88336560 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.86573586 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82647080 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81831891 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80703627 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79096553 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78546774 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77306568 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76605998 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72862362 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.71994266 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70486414 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69610108 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67710759 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.66377579 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64909591 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63905395 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63800342 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.63393170 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.59990764 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.58171690 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57726040 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57250703 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56578396 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56413006 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55234814 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54897315 |
| 87 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53753101 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53230269 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52340641 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51683741 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49954890 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48903479 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47351387 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.47126094 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.46860179 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.46732208 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46623527 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.46490476 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45407878 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.45343701 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43893396 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.43595772 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43455585 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43293628 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42371594 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42117905 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40565295 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40001983 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39951018 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.39058547 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39047258 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38507114 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38070617 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38063989 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38059459 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37501554 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35313703 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34351243 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34173570 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33992881 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33901662 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33797290 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33202634 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.32986912 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.32344020 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31296864 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30696896 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30111969 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29737751 |
| 130 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29628693 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.28543645 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.27896823 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27857331 |
| 134 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27543611 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.27407258 |
| 136 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27102448 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26667054 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26221873 |
| 139 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26173200 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25709030 |
| 141 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24369697 |
| 142 | Spliceosome_Homo sapiens_hsa03040 | 0.23852482 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18275228 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18052878 |
| 145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17085294 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16172981 |
| 147 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.13027796 |

